Langerhans cell histiocytosis with <i>BRAF</i> p.N486_P490del or <i>MAP2K1</i> p.K57_G61del treated by the MEK inhibitor trametinib

Yoav H. Messinger, Michael K. Richards, Bruce Bostrom et al.|Pediatric Blood & Cancer|2020

Cited by 20